Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 0.87 | 2.26 |
NAV | ₹8.18 | ₹169.22 |
Fund Started | 14 Nov 2024 | 13 Oct 2005 |
Fund Size | ₹29.70 Cr | ₹1420.55 Cr |
Exit Load | - | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | - | 9.41% |
3 Year | - | 19.22% |
5 Year | - | 22.37% |
1 Year
3 Year
5 Year
Equity | 99.88% | 96.69% |
Cash | 0.12% | 3.31% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
DLF Ltd. | 20.80% |
Godrej Properties Ltd. | 14.74% |
Lodha Developers Ltd. | 14.43% |
The Phoenix Mills Ltd. | 13.46% |
Prestige Estates Projects Ltd. | 12.62% |
Oberoi Realty Ltd. | 8.98% |
Brigade Enterprises Ltd. | 6.18% |
Anant Raj Ltd. | 3.76% |
Sobha Ltd. | 3.09% |
Signatureglobal (India) Ltd. | 1.82% |
Name | Assets |
|---|---|
Infosys Ltd. | 8.79% |
Reliance Industries Ltd. | 6.82% |
ICICI Bank Ltd. | 6.53% |
HDFC Bank Ltd. | 5.93% |
NTPC Ltd. | 4.63% |
Larsen & Toubro Ltd. | 4.59% |
Bharti Airtel Ltd. | 3.99% |
Sun Pharmaceutical Industries Ltd. | 3.69% |
Tata Consultancy Services Ltd. | 3.01% |
Dr. Reddy's Laboratories Ltd. | 2.87% |
Name | Himanshu Mange | Sri Sharma |
Start Date | 06 Aug 2025 | 30 Apr 2021 |
Name
Start Date
Description | The scheme seeks to provide investment returns that commensurate to the total returns of the securities as represented by the Nifty Realty Index before expenses, subject to tracking errors. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 14 Nov 2024 | 13 Oct 2005 |
Description
Launch Date